Our Mission
GBS Inc. is on a mission to put the power of non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point of care.
With the world-first Biosensor Platform, GBS Inc. is developing and launching diagnostic tests urgently needed to help eradicate COVID-19 and change the lives of people living with diabetes.
Latest News
GBS Inc. Reports Third Quarter 2022 Financial Results and
Recent Business Highlights
– Initiated prospective study to collect coincident samples of oral fluidand blood following IRB approval – – Finalizing site selection at the University of Newcastle campus for the high-tech manufacturing […]
With our world-first Biosensor Platform technology, GBS Inc. will develop and launch an urgently needed non-invasive, real-time diagnostic test.
Behind the Technology
Meet the team at the Centre for Organic Electronics behind the biosensor technology.
